Description: Paul A. Gurbel, MD, discusses clinical guidelines regarding the use of aspirin for antithrombotic therapy, potential mechanisms for aspirin’s therapeutic benefit as well as resistance to aspirin therapy, the results of the ASPECT clinical trial, and monitoring patients for aspirin resistance.